In Brief: Biotech process patent bill
Executive Summary
Biotech process patent bill: House Judiciary/Courts & Intellectual Property Subcommittee reports HR 587 out by voice vote May 16 with no amendments. The bill, which received strong bipartisan support during a March 29 subcommittee hearing, would allow a manufacturer to receive a patent for a biotechnological process if it makes or uses a composition of matter that itself is novel and nonobvious ("The Pink Sheet" April 3, T&G-3). No date has been set for full committee consideration, and there is currently no Senate companion measure...